Programme. More details here…PDIG June 2017
|9.00am||Arrival, Registration, Coffee & Tea|
|10.00am||Chairman’s Welcome & Introduction||Margaret Dolan, Chair, PDIG|
|10.10am|| NHS Medicines Contracting – The Future!
§ What contracting process will be used and what will be the impact upon existing structures and systems?
§ What are the challenges and opportunities?
§ How will the NHS and Pharmaceutical Industry work in partnership?
National Commercial Director,
|10.50am||Specialist Pharmacy Services (SPS) and the National Standardisation programme
§ What is the role of SPS?
§ What is the plan for a Catalogue of NHS-made medicines?
§ What else is on the workplan for NHS-made medicines?
| Tim Root
Clinical Governance & Technical Services,
NHS Specialist Pharmacy Service
|12.00noon||Cancer Medicines – The Transformation
§ How has the funding and evaluation of cancer drugs changed?
§ How will biosimilar monoclonal antibodies be introduced into practice?
§ What are the Cancer Vanguards and how will they impact on cancer treatments?
| David Thomson
Chemotherapy Pharmacist –NHS England
The Royal Marsden NHS Foundation Trust
|2.15pm|| Restricted use of open systems for injectable
medication – background and implications
§ Background to development of patient safety alerts
§ Background to the ‘open systems’ alert
§ Implications of the alert for Pharmacy and the pharmaceutical industry
Head of Patient Safety (Advice and Guidance) NHS Improvement
|2.45pm|| The challenges of NHS Medicines Procurement and
Distribution? – Industry Views A panel discussion
§ What are the most significant current issues?
§ What plans are in place to address these?
§ How can the NHS assist?
| Dr Rick Greville
Director Wales and Director Distribution &
Healthcare Distribution Association
Director General, BGMA
|Summary and Close||Margaret Dolan, Chair, PDIG|